Vancomycin Serum Protein Binding Determination by Ultrafiltration

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Drug Intelligence & Clinical Pharmacy

• Publication date

  1988-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1177/106002808802200404PMID 3371190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein binding of glycopeptide antibiotics with diverse physical-chemical properties in mouse, rat, and human serum

  1987cited by this paper
• Free Drug Monitoring by Liquid Chromatography and Implications for Therapeutic Drug Monitoring

  1987cited by this paper
• Individualized Adjustment of Vancomycin Dosage: Comparison with Two Dosage Nomograms

  1986cited by this paper
• A Simplified Dosing Method for Initiating Vancomycin Therapy

  1985cited by this paper
• Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage.

  1985cited by this paper
• Vancomycin disposition: The importance of age

  1984cited by this paper
• Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay

  1984cited by this paper
• Vancomycin dosage in pediatrics reconsidered.

  1984cited by this paper
• Pharmacokinetics of vancomycin in patients with various degrees of renal function

  1984cited by this paper
• Increased vancomycin dosage requirements in young burn patients

  1984cited by this paper
• Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations

  1982cited by this paper
• Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

  1981cited by this paper
• In Vitro Evaluation of a Vancomycin Radioimmunoassay and Observations on Vancomycin Pharmacokinetics in Dialysis Patients

  1981cited by this paper
• Clinical pharmacology and efficacy of vancomycin in pediatric patients.

  1980cited by this paper
• Single‐Dose Kinetics of Intravenous Vancomycin

  1980cited by this paper
• Pharmacokinetic Data and Drug Monitoring: I. Antibiotics and Antiarrhythmics

  1975cited by this paper
• Renal excretion of vancomycinin in kidney disease.

  1975cited by this paper
• Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis.

  1966cited by this paper
• ANTIBIOTIC THERAPY OF BACTERIAL ENDOCARDITIS.

  1963cited by this paper
• Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary report.

  1958cited by this paper

• Protein binding of vancomycin in a large mixed patient population at a university hospital

  2026cites this paper
• Resolving falsely elevated vancomycin levels in KIMS immunoassay due to monoclonal IgM interference

  2025cites this paper
• Dose optimization and target attainment of vancomycin in children.

  2024cites this paper
• Age-Related Changes in Vancomycin Protein Binding: Is It Time to Take It Seriously?

  2024cites this paper
• Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Vancomycin in Patients with External Ventricular Drain

  2023cites this paper
• Serum Concentration of Continuously administered Vancomycin influences Efficacy and Safety in Critically Ill Adults: A Systematic Review.

  2023cites this paper
• Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022

  2022cites this paper
• Vancomycin therapeutic drug monitoring in patients on continuous renal replacement therapy: a retrospective study

  2022cites this paper
• Pharmacokinetics and pharmacodynamics of peptide antibiotics.

  2022cites this paper
• Efficacy and Safety of Continuous Infusion of Vancomycin in Critically Ill Adults: A Systematic Review

  2022cites this paper
• Lung penetration and pneumococcal target binding of antibiotics in lower respiratory tract infection

  2022cites this paper
• Prediction of Unbound Vancomycin Levels in Intensive Care Unit and Nonintensive Care Unit Patients: Total Bilirubin May Play an Important Role

  2021cites this paper
• Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration

  2021cites this paper
• Halogenated derivatives of methotrexate as human dihydrofolate reductase inhibitors in cancer chemotherapy

  2020cites this paper
• The dosing and monitoring of vancomycin: what is the best way forward?

  2019cites this paper
• A pharmacokinetic comparison of homodimer ARB-92 and heterodimer ARB-89: novel, potent antimalarial candidates derived from 7β-hydroxyartemisinin

  2018cites this paper
• Factors impacting unbound vancomycin concentrations in neonates and young infants

  2018cites this paper
• ASHP Therapeutic Position Statements 685 Therapeutic Monitoring of Vancomycin in Adult Patients : A Consensus Review of the American Society of HealthSystem Pharmacists

  2018cites this paper
• A pharmacokinetic comparison of homodimer ARB-92 and heterodimer ARB-89: novel, potent antimalarial candidates derived from 7β-hydroxyartemisinin

  2017cites this paper
• Combinatory antibiotic therapy increases rate of bacterial kill but not final outcome in a novel mouse model of Staphylococcus aureus spinal implant infection

  2017cites this paper
• Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous hemodiafiltration on different anticoagulant modalities

  2017influential citation
• From Natural Products to Drugs: Glyco- and Lipoglycopeptides, a New Generation of Potent Cell Wall Biosynthesis Inhibitors

  2016cites this paper
• Factors Impacting Unbound Vancomycin Concentrations in Different Patient Populations

  2015cites this paper
• Determination of the free and total concentrations of vancomycin by two-dimensional liquid chromatography and its application in elderly patients.

  2014cites this paper
• Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections

  2014cites this paper
• Combination Prophylactic Therapy with Rifampin Increases Efficacy against an Experimental Staphylococcus epidermidis Subcutaneous Implant-Related Infection

  2014cites this paper
• Underestimation of rat serum vancomycin concentrations measured by an enzyme-multiplied immunoassay technique and the strategy for its avoidance.

  2014cites this paper
• Clinical Laboratory–Based Assay Methodologies May Underestimate and Increase Variability of Vancomycin Protein Binding in Hospitalized Patients

  2014cites this paper
• A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?

  2014cites this paper
• Accuracy of the analysis of free vancomycin concentration by ultrafiltration in various disease states

  2014cites this paper
• Vancomycin intermediate-resistant Staphylococcus aureus : characterization of resistance development, detection and treatment strategies

  2012cites this paper
• Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years.

  2012cites this paper
• Comparison of vancomycin and teicoplanin trough serum levels in patients with infected orthopedic devices: new data for old therapies

  2011cites this paper
• MINIREVIEW Protein Binding: Do We Ever Learn?

  2011cites this paper
• Pharmacokinetics of antibiotics in adults with major burns

  2011cites this paper
• Refining Vancomycin Protein Binding Estimates: Identification of Clinical Factors That Influence Protein Binding

  2011cites this paper
• Protein Binding: Do We Ever Learn?

  2011cites this paper
• Continuing Education: Alternative Approaches to Optimizing Antimicrobial Pharmacodynamics in Critically Ill Patients

  2010cites this paper
• Pharmacokinetics of vancomycin in adult cancer patients

  2010cites this paper
• Class-dependent relevance of tissue distribution in the interpretation of anti-infective pharmacokinetic/pharmacodynamic indices.

  2010cites this paper
• orrelation between free and total vancomycin serum concentrations in atients treated for Gram-positive infections

  2009influential citation
• Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

  2009cites this paper
• ELUTION OF ANTIBIOTICS FROM A NOVEL CROSS-LINKED DEXTRAN GEL : IN VIVO QUANTIFICATION

  2009cites this paper
• Pharmacokinetic/pharmacodynamic characterization of ceftobiprole

  2009cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2008cites this paper
• Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.

  2008cites this paper
• Protein Binding of Antimicrobials: Methods for Quantification and for Investigation of its Impact on Bacterial Killing

  2008cites this paper
• Vancomycin: does it still have a role as an antistaphylococcal agent?

  2007cites this paper
• Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureus.

  2006cites this paper
• The pharmacokinetic and pharmacodynamic properties of vancomycin.

  2006cites this paper
• Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.

  2006cites this paper
• Impaired Target Site Penetration of Vancomycin in Diabetic Patients following Cardiac Surgery

  2006cites this paper
• Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit

  2001cites this paper
• A closer look at vancomycin, teicoplanin, and antimicrobial resistance.

  1997cites this paper
• Ultrafiltration using the Amicon MPS-1 for assessing methadone plasma protein binding.

  1997cites this paper
• Vancomycin‐Binding Characteristics in Patients with Serious Infections

  1996cites this paper
• Therapeutisches Drug Monitoring

  1995cites this paper
• A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system.

  1994cites this paper
• Clinical value of monitoring serum vancomycin concentrations.

  1994cites this paper
• Serum protein-binding characteristics of vancomycin

  1993cites this paper
• Simplified dosing and monitoring of vancomycin for the burn care clinician.

  1992cites this paper
• The influence of vancomycin concentration and the pH of plasma on vancomycin protein binding.

  1992cites this paper
• Amikacin serum protein binding in spinal cord injury.

  1991cites this paper
• Vancomycin Protein Binding in Patients with Infections Caused by Staphylococcus Aureus

  1991cites this paper
• Vancomycin pharmacokinetics in burn patients and intravenous drug abusers

  1990cites this paper
• Protein binding of vancomycin in a patient with immunoglobulin A myeloma

  1990cites this paper
• Comment: vancomycin dosing methods

  1989cites this paper
• Comment: vancomycin dosing methods.

  1989cites this paper
• Semisynthetic glycopeptide antibiotics

  year unknowncites this paper